Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ADHD
Pharma
MHRA raises concerns with switching between long-acting drugs
The notice relates to long-acting ADHD therapies from companies including Johnson & Johnson, Novartis and Takeda.
Nick Paul Taylor
Sep 27, 2022 7:05am
The Adderall supply squeeze in the US is growing
Aug 30, 2022 10:32am
Teva runs into Adderall supply hitch as ADHD diagnoses mount
Aug 3, 2022 10:25am
Game on for Akili as it hires new commercial lead
Jun 10, 2022 11:54am
FDA approves Qelbree, a nonstimulant, for adults with ADHD
May 2, 2022 3:10pm
Supernus taps '90s sitcom actress for ADHD awareness campaign
Oct 28, 2021 9:00am
